
NewsMore in News→
CAR T Therapy’s Next Frontier Is Autoimmune Disease
Key Takeaways
- CAR T cell therapy is being tested in hundreds of autoimmune disease trials.
- Researchers hope the therapy can eliminate self-targeting immune cells and reset the immune system.
- The approach is being explored in multiple sclerosis, lupus, Graves’ disease, vasculitis, and other conditions.
- Major questions remain about durability, safety, and who should receive the treatment.
DE
DT Editorial Team··via arstechnica.com


